The Impact of 24/7-phone Support on Readmission After Aortic Valve Replacement, a Randomized Clinical Trial

Conditions

Aortic Valve Disease

Keywords

telephone support, discharge management, readmission, aortic valve replacement

Brief summary

Aortic Valve Replacement (AVR) surgery for aortic valve disease continues to increase in numbers. With better surgical techniques and equipment, also older patients can be operated on, resulting in an growth of the older population. AVR is characterized by high rates of hospital readmissions, resulting in suboptimal care planning and higher health care costs. Hence, it is important to develop strategies to reduce hospital readmissions following AVR. The purpose if this study is to develop and test the efficacy of a 24/7-phone support in the reduction of readmissions after AVR treatment. Secondary outcomes are a reduced level of anxiety, less depressive symptoms and a better health related quality of life.

Stein Ove Danielsen, Philip Moons, Marit Leegaard, Svein Solheim, Theis Tønnessen et al. (6 authors)

BMC Health Services Research2020-03-275 citations

10.1186/s12913-020-05125-5

Impact of telephone follow-up and 24/7 hotline on 30-day readmission rates following aortic valve replacement -A randomized controlled trial.

Danielsen SO, Moons P, Sandvik L, Leegaard M, Solheim S, Tønnessen T, Lie I.

2019-07-309 citations

10.1016/j.ijcard.2019.07.087

Determining the impact of 24/7 phone support on hospital readmissions after aortic valve replacement surgery (the AVRre study): study protocol for a randomised controlled trial.

Lie I, Danielsen SO, Tønnessen T, Solheim S, Leegaard M, Sandvik L, Wisløff T, Vangen J, Røsstad TH, Moons P.

2017-05-307 citations

10.1186/s13063-017-1971-y

Interventions

OTHER24/7-telephone support

ICU nurses answer the calls from treated AVR patients during the first month after discharge, and use an evidence-based information manual to answer questions from the patients.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

No

Inclusion criteria

* Treatment with AVR (biological or mechanical) single, AVR (b or m)+aortocoronary bypass, AVR (b or m)+supra coronary tube graft * Can understand, speak and write native Language (norwegian), and be able to fill in the questionnaires * Can be contacted by phone after discharge from hospital

Exclusion criteria

* Patients who have been admitted to intensive care for more than 24 hours * Patients who have complications related to surgery e.g. cerebral insult with significant impact on cognitive functions after surgery

Design outcomes

Primary

Measure	Time frame	Description
Reduced readmissions	1 year follow-up	Will use data from the national patient registry: Norway Patient Registry (NPR) and data from patient journals to measure the readmission rates. Main measure will be readmission rate 30 days after discharge for Aortic Valve Replacement (AVR).

Secondary

Measure	Time frame	Description
Reduced anxiety	1 year follow-up	Will use Hospital Anxiety and Depression Scale (HADS) for measuring outcome on anxiety. Measure times: T0: Before AVR, T1: 1 month after AVR, T2: 3 months after AVR, T4: 6 months after AVR, T5: 1 year after AVR
Reduced depression	1 year follow-up	Will use Hospital Anxiety and Depression Scale (HADS) for measuring outcome on depression. Measure times: T0: Before AVR, T1: 1 month after AVR, T2: 3 months after AVR, T4: 6 months after AVR, T5: 1 year after AVR.
Increased health related quality of life	1 year follow-up	Will use EQ-5D-3L questionnaire from The EuroQol Group to measure health related quality of life. Measure times: T0: Before AVR, T1: 1 month after AVR, T2: 3 months after AVR, T4: 6 months after AVR, T5: 1 year after AVR
Reduced costs	1 year follow-up	Will use data from the national patient registry: Norway Patient Registry, data from the patients journals and data from The Norwegian Health Economics Administration (HELFO). Cost-utility analysis to compare intervention group with the control group.

Countries

Norway

Outcome results

None listed